Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Radiation Injuries 3Pancreatic Neoplasms 2Melanoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Vulvar Neoplasms 1Thymoma 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Recurrence 1Rare Diseases 1Pancreatic Cancer Non-resectable 1Ovarian Neoplasms 1Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1

Interventions

Radiotherapy 3pembrolizumab 2fludarabine 2Drug Therapy 2Cyclophosphamide 2zimberelimab 1lenvatinib 1envafolimab 1Thymectomy 1Thoracic Surgery, Video-Assisted 1Radiotherapy, Adjuvant 1Proton Therapy 1Paclitaxel 1Methylprednisolone 1Immunotherapy 1Heavy Ion Radiotherapy 1Carboplatin 1Bupivacaine 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thymoma × Heavy Ion Radiotherapy × Clear all
NCT06186726 2025-06-13

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Shanghai Proton and Heavy Ion Center

Phase 2 Recruiting
48 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡